OncoCyte
Oncocyte Notified That It Lost, Regained Nasdaq Compliance
The issue arose with the death in April of a board member, who was also a member of Oncocyte's audit committee, and was resolved with a new appointment this month.
People in the News at Oncocyte, 10x Genomics
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
Earnings Roundup: DermTech, Exagen, Lucid Diagnostics, Oncocyte
These genomics and molecular diagnostics firms posted their quarterly financial results this week.
Oncocyte, Bio-Rad Partner to Globally Launch Transplant Test
The test is expected to launch in Q2 2024 to select academic transplant centers in the US and EU and more broadly in the second half of the year.
CMS Clarifies Billing Article Revisions for Organ Transplant Rejection Testing
A statement from CMS clarifies that physician-ordered transplant rejection tests remain available when medically necessary.
Jul 24, 2023
Oncocyte Initiates 1-for-20 Reverse Stock Split
Apr 13, 2023